|
TXNDC5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.480800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.349410E-01 |
| Normal-vs-Stage2 |
8.614400E-02 |
| Normal-vs-Stage3 |
8.661000E-03 |
| Normal-vs-Stage4 |
3.202600E-01 |
| Stage1-vs-Stage2 |
4.347600E-01 |
| Stage1-vs-Stage3 |
3.431900E-02 |
| Stage1-vs-Stage4 |
9.221600E-01 |
| Stage2-vs-Stage3 |
3.712000E-01 |
| Stage2-vs-Stage4 |
3.912400E-01 |
| Stage3-vs-Stage4 |
6.677700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.318900E-03 |
| Normal-vs-AfricanAmerican |
1.079350E-01 |
| Normal-vs-Asian |
3.560400E-01 |
| Caucasian-vs-AfricanAmerican |
6.252400E-01 |
| Caucasian-vs-Asian |
8.266000E-01 |
| AfricanAmerican-vs-Asian |
7.151800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.120200E-02 |
| Normal-vs-Female |
3.68570000000012E-05 |
| Male-vs-Female |
6.969000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.062200E-02 |
| Normal-vs-Extreme_Weight |
2.952800E-01 |
| Normal-vs-Obese |
1.282010E-02 |
| Normal-vs-Extreme_Obese |
5.218400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.507820E-01 |
| Normal_Weight-vs-Obese |
9.563400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.484300E-02 |
| Extreme_Weight-vs-Obese |
8.188100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.188200E-01 |
| Obese-vs-Extreme_Obese |
1.197990E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.548300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.062900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.611150E-01 |
| Normal-vs-Age(81-100Yrs) |
5.571200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.575400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.629600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.124200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.872070E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.231500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.985400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.807600E-02 |
| Normal-VS-Type2 PRCC |
6.536200E-02 |
| Normal-VS-KIRP CIMP |
4.633900E-02 |
| Normal-VS-Unclassified PRCC |
1.133750E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.938400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.023190E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.534200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.028000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.657600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.408000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.318580E-01 |
| Normal-vs-N1 |
6.821300E-03 |
| Normal-vs-N2 |
9.197600E-02 |
| N0-vs-N1 |
5.286200E-02 |
| N0-vs-N2 |
5.275000E-01 |
| N1-vs-N2 |
3.308600E-01 |
|
|
